Cancer Biomarkers Market Size, Share, Growth Analysis and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Cancer Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global cancer biomarkers market share, size, growth, trends and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. The global cancer biomarkers market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 53.7 Billion by 2028, exhibiting a growth rate (CAGR) of 12.95% during 2023-2028.

What is Cancer Biomarkers?

Cancer biomarkers are measured in the body of a person to indicate the presence, development, and progression of cancer. They can be found in blood, tissue, and other bodily fluids and provide valuable information for cancer diagnosis, prognosis, and treatment. They can be quantified using various laboratory techniques, which makes them suitable for clinical testing. They enable early cancer detection, increasing the likelihood of successful treatment and improved patient outcomes. They aid in tailoring therapies to individual patients, minimizing side effects, and optimizing treatment effectiveness. They are widely used in screening programs to identify individuals at risk of developing cancer, such as prostate-specific antigen (PSA) for prostate cancer.

Request a PDF sample of report:

Global Industry Trends and Drivers:

The increasing prevalence of cancer worldwide represents one of the key factors catalyzing the demand for cancer biomarkers. Apart from this, the rising adoption of liquid biopsy techniques, which involve the detection of biomarkers in blood or other bodily fluids, is strengthening the growth of the market. Furthermore, the integration of machine learning (ML) and artificial intelligence (AI) in biomarker research and data analysis is accelerating the discovery and validation of new biomarkers. Moreover, patients and healthcare providers are increasingly favoring minimally invasive (MI) diagnostic methods over traditional tissue biopsies, which is positively influencing the market.

What Is Included In Market Segmentation?

The report has been segmented the market into following categories:

Breakup by Profiling Technology:

  • Omic Technologies
  • Imaging Technologies
  • Immunoassays
  • Cytogenetics

Breakup by Biomolecule:

  • Genetic Biomarkers
  • Protein Biomarkers
  • Glyco-Biomarkers

Breakup by Cancer Type:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Others

Breakup by Application:

  • Diagnostics
  • Prognostics
  • Risk Assessment
  • Drug Discovery and Development
  • Others

Breakup by End User:

  • Hospitals
  • Academic and Research Institutions
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report provides a comprehensive analysis of the industry key players listed below:

Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc. and Thermo Fisher Scientific Inc.

Key highlights of the Report:

  • Market Performance (2018-2023)
  • Market Outlook (2023-2028)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

TOC for the Report:

  • Preface
  • Scope and Methodology
  • Executive Summary
  • Introduction
  • SWOT Analysis
  • Value Chain Analysis
  • Price Analysis
  • Competitive Landscape